- 0
- 207 words
Updated on: August 31, 2026 / 4:38 PM EDT / CBS News
\n\nPresident Trump said Monday that his administration has signed agreements with nine additional pharmaceutical firms to offer discounted drugs to state Medicaid programs.
\n\n"In total, these agreements are projected to save Americans more than $600 billion over a very short period of time," Mr. Trump said during an announcement at the Oval Office.
\n\nThe announcement is part of Mr. Trump's "most-favored-nation" drug pricing policy, aimed at offering drugs in the U.S. at a comparable price to that in other developed nations. The effort involves selling discounted drugs directly to consumers on TrumpRx, a website the Trump administration launched in February, where Americans can get discounts on name-brand medications.
\n\nSeventeen pharmaceutical companies have already agreed to voluntarily lower their drug prices as part of the "most favored nation" deal over the last year, according to the White House.
\n\n"With today's announcement, we now have 26 companies representing 90% of the domestic pharmaceutical market, and the other 10% are also coming in," Mr. Trump said. "They have no choice."
\n\nThe nine new firms that have agreed to offer consumer discounts are midsize pharmaceutical firms, according to a White House fact…
Original source: https://www.cbsnews.com/healthwatch/
